Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TSC2 |
Variant | G62E |
Impact List | missense |
Protein Effect | no effect - predicted |
Gene Variant Descriptions | TSC2 G62E lies within the TSC1-interacting region of the Tsc2 protein (UniProt.org). G62E results in inhibition of S6k phosphorylation similar to wild-type Tsc2 in cell culture (PMID: 18854862), and therefore, is predicted to have no effect on Tsc2 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
TSC2 mutant TSC2 G62E |
Transcript | NM_000548.5 |
gDNA | chr16:g.2050446G>A |
cDNA | c.185G>A |
Protein | p.G62E |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_005255529.4 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
XM_024450413.1 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
XM_011522636.3 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001406675.1 | chr16:g.2053448G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
XM_017023616.1 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
XM_011522639.2 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
XM_005255531.4 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001370404.1 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001114382.2 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001406663.1 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
XM_011522637.2 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_021055.3 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_000548.5 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001406671.1 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
XM_011522636.2 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001370405.1 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001406678.1 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001406668.1 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001077183.3 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001363528.2 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001406673.1 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001318827.1 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
XM_011522637.3 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001406664.1 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001318829.2 | chr16:g.2053448G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
XM_017023615.1 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001114382.3 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
XM_011522639.3 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
XM_011522638.3 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001406676.1 | chr16:g.2053448G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
XM_011522640.2 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001406670.1 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001406679.1 | chr16:g.2053448G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001406665.1 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001406677.1 | chr16:g.2053448G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001406667.1 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_001318827.2 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
NM_000548.4 | chr16:g.2050446G>A | c.185G>A | p.G62E | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|